Pfizer purchases ARNA 50% premium $100 share for 6.7 billion for ulcer colitis main drug. Amazing that drug is valued 6.7 billion which is 10x CYDY current market cap. Considering CYDY has revenue path 50-100x more than ARNA. Only reason cydy has not been bought out because current management will not accept pennies on dollar. Big pharm have instead thrown everything but kitchen sink at CYDY. Using connections with FDA, MM, Shorts, Censorship, media etc….

They have made a concerted effort as Alice mentions horse racing everyone knows CYDY is the favorite for triple crown horse that hasn’t been in any big races just yet but has blown away all competition in phase 1-2 trials. Its all lining up for CYDY to become a Big Pharma themselves. If we had just one approval 2 years ago HIV for example, we would have been bought out for a nice profit at the time, but that was before all data we have now on Covid Severe, Covid Critical, Covid Long haulers, MTNBC, NASH and many other cancer and immunology diseases. CYDY has very solid foundation, it is only up from here the base is to strong to crumble CYDY will come out stronger than ever after beating it took last year. What doesn’t kill ya makes you stronger!